Tag: Type 2 Diabetes
-
Preservatives Linked to Type 2 Diabetes and Cancer Risk: What the New Studies Show
New Findings on Preservatives and Health Risks Recent research is prompting a closer look at certain food preservatives and their potential links to Type 2 diabetes and cancer risk. While food additives play a crucial role in extending shelf life and maintaining safety, some studies suggest that particular preservatives could influence metabolic and cellular processes…
-
Food Preservatives Linked to Type 2 Diabetes and Cancer Risk: What New Studies Show
Overview of the Findings Recent research highlights potential links between certain food preservatives and increased health risks, including Type 2 diabetes and some forms of cancer. While preservatives play a vital role in food safety, helping to prevent spoilage and extend shelf life, scientists are increasingly examining how long-term exposure to these additives might influence…
-
Incretin-Based Diabetes Drugs May Protect Against Dementia
Groundbreaking Findings from a Large-Scale McGill Study In a landmark analysis drawing on real-world clinical data from more than 450,000 patients, researchers at McGill University report that two classes of incretin-based medications used to treat Type 2 diabetes are associated with a reduced risk of dementia. The study adds to a growing body of evidence…
-
Incretin-Based Diabetes Drugs May Lower Dementia Risk, McGill Study Finds
Overview: A New Link Between Diabetes Medications and Dementia Risk A landmark study from McGill University has raised hopes that two classes of incretin-based diabetes drugs could offer protective effects against dementia. In a vast analysis drawing on clinical data from more than 450,000 patients, researchers found an association between the use of incretin-based therapies…
-
International Consensus Guides Diabetes Technology Use During Pregnancy
New Consensus Sets Global Standards for Diabetes Technology in Pregnancy In a landmark move, the diaTribe Foundation released the first international consensus statement focused on the use of continuous glucose monitoring (CGM) and automated insulin delivery (AID) during pregnancy. The guidance is designed to help clinicians, pregnant people with diabetes, and their care teams navigate…
-
Beyond weight loss: How Semaglutide cuts heart risk faster than the scale moves
Introduction: The heart benefits most patients want Semaglutide, a medication originally developed to help manage type 2 diabetes and support weight loss, has found a broader role in cardiovascular health. While the scale may take time to show dramatic change, researchers and clinicians are discovering that semaglutide can lower heart risk parameters sooner than expected.…
-
NHS Urges GP Visit Now if You Have Three Symptoms While Taking Dapagliflozin
H2: What is dapagliflozin and who uses it? Dapagliflozin is a medication commonly prescribed to manage type 2 diabetes, helping the kidneys remove excess sugar through urine. It is also used in some patients with heart failure and chronic kidney disease to protect organ function and improve outcomes. While it can offer important benefits, it…
-
Global Diabetes Projections 2050: IDF’s Alarm Bell and What It Means for Health Systems
Overview of the 2050 Projection The International Diabetes Federation (IDF) has released the 11th edition of its Diabetes Atlas, marking a stark forecast: the global number of people living with diabetes could rise from about 500 million in 2024 to nearly 900 million by 2050. This projection, if realized, would place immense pressure on healthcare…
-
Global Diabetes Crisis: IDF Projects 900 Million Cases by 2050
The Growing Global Burden of Diabetes The International Diabetes Federation (IDF) Deutsche Atlas, in its 11th edition, projects a striking rise in diabetes prevalence worldwide. Based on data from 2024 and demographics trends, the atlas estimates that the number of people living with diabetes could surge from about 500 million in 2024 to nearly 900…
-
Hearing Loss Risk in Type 2 Diabetes: What Patients Should Know
Overview Hearing health is a growing concern for adults with type 2 diabetes. A review published in the November issue of Otolaryngology-Head and Neck Surgery highlights that individuals with type 2 diabetes have a noticeably higher risk of developing hearing loss compared with people without diabetes. While the exact mechanisms remain under study, the finding…